Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and ...
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: The OPTIMISE-CKD CEE study, officially titled ‘A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback